Comparing Glucose-Lowering Drugs for Type 2 Diabetes Treatment According to CVD Risk
In patients who have type 2 diabetes and low cardiovascular risk, receiving metformin as first-line therapy appears justified.
In patients who have type 2 diabetes and low cardiovascular risk, receiving metformin as first-line therapy appears justified.
Researchers found that lower levels of estrogen during menstruation cause women to be more vulnerable to migraines than men.
A pharmacist-led, postdischarge structured telephone follow-up intervention can reduce 30-day and 90-day readmission rates for polypharmacy patients.